Skip to Main Content

Paper Details

A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma.
Cancer Res
21
2020
CD79B, CD79B mutations, CNSL, CNSL xenografts, EBV, EBV-positive, EBV-positive PCNSL, Epstein-Barr virus, FDG, Hexokinase 2, LMP1, MYD88, MYD88 and CD79B mutations, PCNSL, PDXs, Pin1, Primary Central Nervous System Lymphoma, Primary central nervous system lymphoma, RelA, cancerres, hexokinase 2, immunocompetent, lymphoma of the central nervous system, p65, patient, patient-derived xenograft (PDX) models, patients, tumor
Author NameAffiliation
Hiroyuki ManoNational Cancer Center Research Institute
Andrew S Chi
Tracy T BatchelorBrigham and Women's Hospital and Harvard Medical School
Tracy T BatchelorBrigham and Women's Hospital and Harvard Medical School
Motoo NaganeKyorin University Faculty of Medicine
  • 1 - 5

Datasets

Release 1.2